aluates Reports

$ 0.0

Automative

Global Small Molecule CXO Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-23N12334

Global Small Molecule CXO Industry Research Report Growth Trends and Competitive Analysis 2022 2028

BUY CHAPTERS

Global Small Molecule CXO Market Research Report 2025

Code: QYRE-Auto-23N12334

Report

June 2025

Pages:114

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

IQVIA

LabCorp

PPD

Pharmablock

Asym Chemical

Jiuzhou Pharmaceutical

Pharmaron Beijing

Porton Pharma

ChemPartner

Tigermed

Shanghai Medicilon

ICON

PRA Health

Syneos Health

VIVA Biotech Holdings

Chengdu Hitgen

Nanjing Genscript

Lonza

Catalent

Thermo Fisher

Delpharm

Aenova Group

Siegfried Holding AG

Recipharm

FAREVA SA

Almac Group

Cambrex

Charles River

Corden Pharma

WuXi AppTec

Small Molecule CXO Market Size

The global market for Small Molecule CXO was valued at US$ 60520 million in the year 2024 and is projected to reach a revised size of US$ 151400 million by 2031, growing at a CAGR of 14.2% during the forecast period.

Small Molecule CXO Market

North American market for Small Molecule CXO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Small Molecule CXO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Small Molecule CXO in Pharmaceutical is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Small Molecule CXO include IQVIA, Labcorp, PPD, Wuxi Apptec, PharmaBlock, Asym Chemical, Jiuzhou Pharmaceutical, Pharmaron Beijing, Porton Pharma, ChemPartner, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Small Molecule CXO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule CXO.

The Small Molecule CXO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Small Molecule CXO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Small Molecule CXO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Small Molecule CXO Market Report

Report Metric	Details
Report Name	Small Molecule CXO Market
Accounted market size in year	US$ 60520 million
Forecasted market size in 2031	US$ 151400 million
CAGR	14.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	CRO CMC CDMO CMO
Segment by Application	Pharmaceutical Biotechnology
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	IQVIA, Labcorp, PPD, Wuxi Apptec, PharmaBlock, Asym Chemical, Jiuzhou Pharmaceutical, Pharmaron Beijing, Porton Pharma, ChemPartner, Tigermed, Shanghai Medicilon, VIVA Biotech Holdings, Chengdu Hitgen, Nanjing Genscript, ICON plc, PRA Health, Syneos Health, Lonza, Catalent, Thermo Fisher, DELPHARM, Aenova Group, Siegfried Holding AG, Recipharm AB, FAREVA SA, Almac Group, Cambrex, Charles River, CORDEN PHARMA
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Molecule CXO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Small Molecule CXO Market growing?

Ans: The Small Molecule CXO Market witnessing a CAGR of 14.2% during the forecast period 2025-2031.

What is the Small Molecule CXO Market size in 2031?

Ans: The Small Molecule CXO Market size in 2031 will be US$ 151400 million.

Who are the main players in the Small Molecule CXO Market report?

Ans: The main players in the Small Molecule CXO Market are IQVIA, Labcorp, PPD, Wuxi Apptec, PharmaBlock, Asym Chemical, Jiuzhou Pharmaceutical, Pharmaron Beijing, Porton Pharma, ChemPartner, Tigermed, Shanghai Medicilon, VIVA Biotech Holdings, Chengdu Hitgen, Nanjing Genscript, ICON plc, PRA Health, Syneos Health, Lonza, Catalent, Thermo Fisher, DELPHARM, Aenova Group, Siegfried Holding AG, Recipharm AB, FAREVA SA, Almac Group, Cambrex, Charles River, CORDEN PHARMA

What are the Application segmentation covered in the Small Molecule CXO Market report?

Ans: The Applications covered in the Small Molecule CXO Market report are Pharmaceutical, Biotechnology

What are the Type segmentation covered in the Small Molecule CXO Market report?

Ans: The Types covered in the Small Molecule CXO Market report are CRO, CMC, CDMO, CMO

Recommended Reports

Small Molecule Markets

CDMO & CRO Services

Pharmaceutical Cold Chain

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Small Molecule CXO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 CRO

1.2.3 CMC

1.2.4 CDMO

1.2.5 CMO

1.3 Market by Application

1.3.1 Global Small Molecule CXO Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical

1.3.3 Biotechnology

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Small Molecule CXO Market Perspective (2020-2031)

2.2 Global Small Molecule CXO Growth Trends by Region

2.2.1 Global Small Molecule CXO Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Small Molecule CXO Historic Market Size by Region (2020-2025)

2.2.3 Small Molecule CXO Forecasted Market Size by Region (2026-2031)

2.3 Small Molecule CXO Market Dynamics

2.3.1 Small Molecule CXO Industry Trends

2.3.2 Small Molecule CXO Market Drivers

2.3.3 Small Molecule CXO Market Challenges

2.3.4 Small Molecule CXO Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Small Molecule CXO Players by Revenue

3.1.1 Global Top Small Molecule CXO Players by Revenue (2020-2025)

3.1.2 Global Small Molecule CXO Revenue Market Share by Players (2020-2025)

3.2 Global Small Molecule CXO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Small Molecule CXO Revenue

3.4 Global Small Molecule CXO Market Concentration Ratio

3.4.1 Global Small Molecule CXO Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Small Molecule CXO Revenue in 2024

3.5 Global Key Players of Small Molecule CXO Head office and Area Served

3.6 Global Key Players of Small Molecule CXO, Product and Application

3.7 Global Key Players of Small Molecule CXO, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Small Molecule CXO Breakdown Data by Type

4.1 Global Small Molecule CXO Historic Market Size by Type (2020-2025)

4.2 Global Small Molecule CXO Forecasted Market Size by Type (2026-2031)

5 Small Molecule CXO Breakdown Data by Application

5.1 Global Small Molecule CXO Historic Market Size by Application (2020-2025)

5.2 Global Small Molecule CXO Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Small Molecule CXO Market Size (2020-2031)

6.2 North America Small Molecule CXO Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Small Molecule CXO Market Size by Country (2020-2025)

6.4 North America Small Molecule CXO Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Small Molecule CXO Market Size (2020-2031)

7.2 Europe Small Molecule CXO Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Small Molecule CXO Market Size by Country (2020-2025)

7.4 Europe Small Molecule CXO Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Small Molecule CXO Market Size (2020-2031)

8.2 Asia-Pacific Small Molecule CXO Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Small Molecule CXO Market Size by Region (2020-2025)

8.4 Asia-Pacific Small Molecule CXO Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Small Molecule CXO Market Size (2020-2031)

9.2 Latin America Small Molecule CXO Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Small Molecule CXO Market Size by Country (2020-2025)

9.4 Latin America Small Molecule CXO Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Small Molecule CXO Market Size (2020-2031)

10.2 Middle East & Africa Small Molecule CXO Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Small Molecule CXO Market Size by Country (2020-2025)

10.4 Middle East & Africa Small Molecule CXO Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 IQVIA

11.1.1 IQVIA Company Details

11.1.2 IQVIA Business Overview

11.1.3 IQVIA Small Molecule CXO Introduction

11.1.4 IQVIA Revenue in Small Molecule CXO Business (2020-2025)

11.1.5 IQVIA Recent Development

11.2 Labcorp

11.2.1 Labcorp Company Details

11.2.2 Labcorp Business Overview

11.2.3 Labcorp Small Molecule CXO Introduction

11.2.4 Labcorp Revenue in Small Molecule CXO Business (2020-2025)

11.2.5 Labcorp Recent Development

11.3 PPD

11.3.1 PPD Company Details

11.3.2 PPD Business Overview

11.3.3 PPD Small Molecule CXO Introduction

11.3.4 PPD Revenue in Small Molecule CXO Business (2020-2025)

11.3.5 PPD Recent Development

11.4 Wuxi Apptec

11.4.1 Wuxi Apptec Company Details

11.4.2 Wuxi Apptec Business Overview

11.4.3 Wuxi Apptec Small Molecule CXO Introduction

11.4.4 Wuxi Apptec Revenue in Small Molecule CXO Business (2020-2025)

11.4.5 Wuxi Apptec Recent Development

11.5 PharmaBlock

11.5.1 PharmaBlock Company Details

11.5.2 PharmaBlock Business Overview

11.5.3 PharmaBlock Small Molecule CXO Introduction

11.5.4 PharmaBlock Revenue in Small Molecule CXO Business (2020-2025)

11.5.5 PharmaBlock Recent Development

11.6 Asym Chemical

11.6.1 Asym Chemical Company Details

11.6.2 Asym Chemical Business Overview

11.6.3 Asym Chemical Small Molecule CXO Introduction

11.6.4 Asym Chemical Revenue in Small Molecule CXO Business (2020-2025)

11.6.5 Asym Chemical Recent Development

11.7 Jiuzhou Pharmaceutical

11.7.1 Jiuzhou Pharmaceutical Company Details

11.7.2 Jiuzhou Pharmaceutical Business Overview

11.7.3 Jiuzhou Pharmaceutical Small Molecule CXO Introduction

11.7.4 Jiuzhou Pharmaceutical Revenue in Small Molecule CXO Business (2020-2025)

11.7.5 Jiuzhou Pharmaceutical Recent Development

11.8 Pharmaron Beijing

11.8.1 Pharmaron Beijing Company Details

11.8.2 Pharmaron Beijing Business Overview

11.8.3 Pharmaron Beijing Small Molecule CXO Introduction

11.8.4 Pharmaron Beijing Revenue in Small Molecule CXO Business (2020-2025)

11.8.5 Pharmaron Beijing Recent Development

11.9 Porton Pharma

11.9.1 Porton Pharma Company Details

11.9.2 Porton Pharma Business Overview

11.9.3 Porton Pharma Small Molecule CXO Introduction

11.9.4 Porton Pharma Revenue in Small Molecule CXO Business (2020-2025)

11.9.5 Porton Pharma Recent Development

11.10 ChemPartner

11.10.1 ChemPartner Company Details

11.10.2 ChemPartner Business Overview

11.10.3 ChemPartner Small Molecule CXO Introduction

11.10.4 ChemPartner Revenue in Small Molecule CXO Business (2020-2025)

11.10.5 ChemPartner Recent Development

11.11 Tigermed

11.11.1 Tigermed Company Details

11.11.2 Tigermed Business Overview

11.11.3 Tigermed Small Molecule CXO Introduction

11.11.4 Tigermed Revenue in Small Molecule CXO Business (2020-2025)

11.11.5 Tigermed Recent Development

11.12 Shanghai Medicilon

11.12.1 Shanghai Medicilon Company Details

11.12.2 Shanghai Medicilon Business Overview

11.12.3 Shanghai Medicilon Small Molecule CXO Introduction

11.12.4 Shanghai Medicilon Revenue in Small Molecule CXO Business (2020-2025)

11.12.5 Shanghai Medicilon Recent Development

11.13 VIVA Biotech Holdings

11.13.1 VIVA Biotech Holdings Company Details

11.13.2 VIVA Biotech Holdings Business Overview

11.13.3 VIVA Biotech Holdings Small Molecule CXO Introduction

11.13.4 VIVA Biotech Holdings Revenue in Small Molecule CXO Business (2020-2025)

11.13.5 VIVA Biotech Holdings Recent Development

11.14 Chengdu Hitgen

11.14.1 Chengdu Hitgen Company Details

11.14.2 Chengdu Hitgen Business Overview

11.14.3 Chengdu Hitgen Small Molecule CXO Introduction

11.14.4 Chengdu Hitgen Revenue in Small Molecule CXO Business (2020-2025)

11.14.5 Chengdu Hitgen Recent Development

11.15 Nanjing Genscript

11.15.1 Nanjing Genscript Company Details

11.15.2 Nanjing Genscript Business Overview

11.15.3 Nanjing Genscript Small Molecule CXO Introduction

11.15.4 Nanjing Genscript Revenue in Small Molecule CXO Business (2020-2025)

11.15.5 Nanjing Genscript Recent Development

11.16 ICON plc

11.16.1 ICON plc Company Details

11.16.2 ICON plc Business Overview

11.16.3 ICON plc Small Molecule CXO Introduction

11.16.4 ICON plc Revenue in Small Molecule CXO Business (2020-2025)

11.16.5 ICON plc Recent Development

11.17 PRA Health

11.17.1 PRA Health Company Details

11.17.2 PRA Health Business Overview

11.17.3 PRA Health Small Molecule CXO Introduction

11.17.4 PRA Health Revenue in Small Molecule CXO Business (2020-2025)

11.17.5 PRA Health Recent Development

11.18 Syneos Health

11.18.1 Syneos Health Company Details

11.18.2 Syneos Health Business Overview

11.18.3 Syneos Health Small Molecule CXO Introduction

11.18.4 Syneos Health Revenue in Small Molecule CXO Business (2020-2025)

11.18.5 Syneos Health Recent Development

11.19 Lonza

11.19.1 Lonza Company Details

11.19.2 Lonza Business Overview

11.19.3 Lonza Small Molecule CXO Introduction

11.19.4 Lonza Revenue in Small Molecule CXO Business (2020-2025)

11.19.5 Lonza Recent Development

11.20 Catalent

11.20.1 Catalent Company Details

11.20.2 Catalent Business Overview

11.20.3 Catalent Small Molecule CXO Introduction

11.20.4 Catalent Revenue in Small Molecule CXO Business (2020-2025)

11.20.5 Catalent Recent Development

11.21 Thermo Fisher

11.21.1 Thermo Fisher Company Details

11.21.2 Thermo Fisher Business Overview

11.21.3 Thermo Fisher Small Molecule CXO Introduction

11.21.4 Thermo Fisher Revenue in Small Molecule CXO Business (2020-2025)

11.21.5 Thermo Fisher Recent Development

11.22 DELPHARM

11.22.1 DELPHARM Company Details

11.22.2 DELPHARM Business Overview

11.22.3 DELPHARM Small Molecule CXO Introduction

11.22.4 DELPHARM Revenue in Small Molecule CXO Business (2020-2025)

11.22.5 DELPHARM Recent Development

11.23 Aenova Group

11.23.1 Aenova Group Company Details

11.23.2 Aenova Group Business Overview

11.23.3 Aenova Group Small Molecule CXO Introduction

11.23.4 Aenova Group Revenue in Small Molecule CXO Business (2020-2025)

11.23.5 Aenova Group Recent Development

11.24 Siegfried Holding AG

11.24.1 Siegfried Holding AG Company Details

11.24.2 Siegfried Holding AG Business Overview

11.24.3 Siegfried Holding AG Small Molecule CXO Introduction

11.24.4 Siegfried Holding AG Revenue in Small Molecule CXO Business (2020-2025)

11.24.5 Siegfried Holding AG Recent Development

11.25 Recipharm AB

11.25.1 Recipharm AB Company Details

11.25.2 Recipharm AB Business Overview

11.25.3 Recipharm AB Small Molecule CXO Introduction

11.25.4 Recipharm AB Revenue in Small Molecule CXO Business (2020-2025)

11.25.5 Recipharm AB Recent Development

11.26 FAREVA SA

11.26.1 FAREVA SA Company Details

11.26.2 FAREVA SA Business Overview

11.26.3 FAREVA SA Small Molecule CXO Introduction

11.26.4 FAREVA SA Revenue in Small Molecule CXO Business (2020-2025)

11.26.5 FAREVA SA Recent Development

11.27 Almac Group

11.27.1 Almac Group Company Details

11.27.2 Almac Group Business Overview

11.27.3 Almac Group Small Molecule CXO Introduction

11.27.4 Almac Group Revenue in Small Molecule CXO Business (2020-2025)

11.27.5 Almac Group Recent Development

11.28 Cambrex

11.28.1 Cambrex Company Details

11.28.2 Cambrex Business Overview

11.28.3 Cambrex Small Molecule CXO Introduction

11.28.4 Cambrex Revenue in Small Molecule CXO Business (2020-2025)

11.28.5 Cambrex Recent Development

11.29 Charles River

11.29.1 Charles River Company Details

11.29.2 Charles River Business Overview

11.29.3 Charles River Small Molecule CXO Introduction

11.29.4 Charles River Revenue in Small Molecule CXO Business (2020-2025)

11.29.5 Charles River Recent Development

11.30 CORDEN PHARMA

11.30.1 CORDEN PHARMA Company Details

11.30.2 CORDEN PHARMA Business Overview

11.30.3 CORDEN PHARMA Small Molecule CXO Introduction

11.30.4 CORDEN PHARMA Revenue in Small Molecule CXO Business (2020-2025)

11.30.5 CORDEN PHARMA Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

IQVIA

LabCorp

PPD

Pharmablock

Asym Chemical

Jiuzhou Pharmaceutical

Pharmaron Beijing

Porton Pharma

ChemPartner

Tigermed

Shanghai Medicilon

ICON

PRA Health

Syneos Health

VIVA Biotech Holdings

Chengdu Hitgen

Nanjing Genscript

Lonza

Catalent

Thermo Fisher

Delpharm

Aenova Group

Siegfried Holding AG

Recipharm

FAREVA SA

Almac Group

Cambrex

Charles River

Corden Pharma

WuXi AppTec

List of Tables

Table 1. Global Small Molecule CXO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of CRO

Table 3. Key Players of CMC

Table 4. Key Players of CDMO

Table 5. Key Players of CMO

Table 6. Global Small Molecule CXO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Small Molecule CXO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Small Molecule CXO Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Small Molecule CXO Market Share by Region (2020-2025)

Table 10. Global Small Molecule CXO Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Small Molecule CXO Market Share by Region (2026-2031)

Table 12. Small Molecule CXO Market Trends

Table 13. Small Molecule CXO Market Drivers

Table 14. Small Molecule CXO Market Challenges

Table 15. Small Molecule CXO Market Restraints

Table 16. Global Small Molecule CXO Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Small Molecule CXO Market Share by Players (2020-2025)

Table 18. Global Top Small Molecule CXO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule CXO as of 2024)

Table 19. Ranking of Global Top Small Molecule CXO Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Small Molecule CXO Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Small Molecule CXO, Headquarters and Area Served

Table 22. Global Key Players of Small Molecule CXO, Product and Application

Table 23. Global Key Players of Small Molecule CXO, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Small Molecule CXO Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Small Molecule CXO Revenue Market Share by Type (2020-2025)

Table 27. Global Small Molecule CXO Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Small Molecule CXO Revenue Market Share by Type (2026-2031)

Table 29. Global Small Molecule CXO Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Small Molecule CXO Revenue Market Share by Application (2020-2025)

Table 31. Global Small Molecule CXO Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Small Molecule CXO Revenue Market Share by Application (2026-2031)

Table 33. North America Small Molecule CXO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Small Molecule CXO Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Small Molecule CXO Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Small Molecule CXO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Small Molecule CXO Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Small Molecule CXO Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Small Molecule CXO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Small Molecule CXO Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Small Molecule CXO Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Small Molecule CXO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Small Molecule CXO Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Small Molecule CXO Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Small Molecule CXO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Small Molecule CXO Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Small Molecule CXO Market Size by Country (2026-2031) & (US$ Million)

Table 48. IQVIA Company Details

Table 49. IQVIA Business Overview

Table 50. IQVIA Small Molecule CXO Product

Table 51. IQVIA Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 52. IQVIA Recent Development

Table 53. Labcorp Company Details

Table 54. Labcorp Business Overview

Table 55. Labcorp Small Molecule CXO Product

Table 56. Labcorp Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 57. Labcorp Recent Development

Table 58. PPD Company Details

Table 59. PPD Business Overview

Table 60. PPD Small Molecule CXO Product

Table 61. PPD Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 62. PPD Recent Development

Table 63. Wuxi Apptec Company Details

Table 64. Wuxi Apptec Business Overview

Table 65. Wuxi Apptec Small Molecule CXO Product

Table 66. Wuxi Apptec Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 67. Wuxi Apptec Recent Development

Table 68. PharmaBlock Company Details

Table 69. PharmaBlock Business Overview

Table 70. PharmaBlock Small Molecule CXO Product

Table 71. PharmaBlock Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 72. PharmaBlock Recent Development

Table 73. Asym Chemical Company Details

Table 74. Asym Chemical Business Overview

Table 75. Asym Chemical Small Molecule CXO Product

Table 76. Asym Chemical Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 77. Asym Chemical Recent Development

Table 78. Jiuzhou Pharmaceutical Company Details

Table 79. Jiuzhou Pharmaceutical Business Overview

Table 80. Jiuzhou Pharmaceutical Small Molecule CXO Product

Table 81. Jiuzhou Pharmaceutical Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 82. Jiuzhou Pharmaceutical Recent Development

Table 83. Pharmaron Beijing Company Details

Table 84. Pharmaron Beijing Business Overview

Table 85. Pharmaron Beijing Small Molecule CXO Product

Table 86. Pharmaron Beijing Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 87. Pharmaron Beijing Recent Development

Table 88. Porton Pharma Company Details

Table 89. Porton Pharma Business Overview

Table 90. Porton Pharma Small Molecule CXO Product

Table 91. Porton Pharma Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 92. Porton Pharma Recent Development

Table 93. ChemPartner Company Details

Table 94. ChemPartner Business Overview

Table 95. ChemPartner Small Molecule CXO Product

Table 96. ChemPartner Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 97. ChemPartner Recent Development

Table 98. Tigermed Company Details

Table 99. Tigermed Business Overview

Table 100. Tigermed Small Molecule CXO Product

Table 101. Tigermed Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 102. Tigermed Recent Development

Table 103. Shanghai Medicilon Company Details

Table 104. Shanghai Medicilon Business Overview

Table 105. Shanghai Medicilon Small Molecule CXO Product

Table 106. Shanghai Medicilon Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 107. Shanghai Medicilon Recent Development

Table 108. VIVA Biotech Holdings Company Details

Table 109. VIVA Biotech Holdings Business Overview

Table 110. VIVA Biotech Holdings Small Molecule CXO Product

Table 111. VIVA Biotech Holdings Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 112. VIVA Biotech Holdings Recent Development

Table 113. Chengdu Hitgen Company Details

Table 114. Chengdu Hitgen Business Overview

Table 115. Chengdu Hitgen Small Molecule CXO Product

Table 116. Chengdu Hitgen Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 117. Chengdu Hitgen Recent Development

Table 118. Nanjing Genscript Company Details

Table 119. Nanjing Genscript Business Overview

Table 120. Nanjing Genscript Small Molecule CXO Product

Table 121. Nanjing Genscript Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 122. Nanjing Genscript Recent Development

Table 123. ICON plc Company Details

Table 124. ICON plc Business Overview

Table 125. ICON plc Small Molecule CXO Product

Table 126. ICON plc Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 127. ICON plc Recent Development

Table 128. PRA Health Company Details

Table 129. PRA Health Business Overview

Table 130. PRA Health Small Molecule CXO Product

Table 131. PRA Health Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 132. PRA Health Recent Development

Table 133. Syneos Health Company Details

Table 134. Syneos Health Business Overview

Table 135. Syneos Health Small Molecule CXO Product

Table 136. Syneos Health Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 137. Syneos Health Recent Development

Table 138. Lonza Company Details

Table 139. Lonza Business Overview

Table 140. Lonza Small Molecule CXO Product

Table 141. Lonza Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 142. Lonza Recent Development

Table 143. Catalent Company Details

Table 144. Catalent Business Overview

Table 145. Catalent Small Molecule CXO Product

Table 146. Catalent Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 147. Catalent Recent Development

Table 148. Thermo Fisher Company Details

Table 149. Thermo Fisher Business Overview

Table 150. Thermo Fisher Small Molecule CXO Product

Table 151. Thermo Fisher Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 152. Thermo Fisher Recent Development

Table 153. DELPHARM Company Details

Table 154. DELPHARM Business Overview

Table 155. DELPHARM Small Molecule CXO Product

Table 156. DELPHARM Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 157. DELPHARM Recent Development

Table 158. Aenova Group Company Details

Table 159. Aenova Group Business Overview

Table 160. Aenova Group Small Molecule CXO Product

Table 161. Aenova Group Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 162. Aenova Group Recent Development

Table 163. Siegfried Holding AG Company Details

Table 164. Siegfried Holding AG Business Overview

Table 165. Siegfried Holding AG Small Molecule CXO Product

Table 166. Siegfried Holding AG Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 167. Siegfried Holding AG Recent Development

Table 168. Recipharm AB Company Details

Table 169. Recipharm AB Business Overview

Table 170. Recipharm AB Small Molecule CXO Product

Table 171. Recipharm AB Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 172. Recipharm AB Recent Development

Table 173. FAREVA SA Company Details

Table 174. FAREVA SA Business Overview

Table 175. FAREVA SA Small Molecule CXO Product

Table 176. FAREVA SA Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 177. FAREVA SA Recent Development

Table 178. Almac Group Company Details

Table 179. Almac Group Business Overview

Table 180. Almac Group Small Molecule CXO Product

Table 181. Almac Group Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 182. Almac Group Recent Development

Table 183. Cambrex Company Details

Table 184. Cambrex Business Overview

Table 185. Cambrex Small Molecule CXO Product

Table 186. Cambrex Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 187. Cambrex Recent Development

Table 188. Charles River Company Details

Table 189. Charles River Business Overview

Table 190. Charles River Small Molecule CXO Product

Table 191. Charles River Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 192. Charles River Recent Development

Table 193. CORDEN PHARMA Company Details

Table 194. CORDEN PHARMA Business Overview

Table 195. CORDEN PHARMA Small Molecule CXO Product

Table 196. CORDEN PHARMA Revenue in Small Molecule CXO Business (2020-2025) & (US$ Million)

Table 197. CORDEN PHARMA Recent Development

Table 198. Research Programs/Design for This Report

Table 199. Key Data Information from Secondary Sources

Table 200. Key Data Information from Primary Sources

Table 201. Authors List of This Report

List of Figures

Figure 1. Small Molecule CXO Picture

Figure 2. Global Small Molecule CXO Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Small Molecule CXO Market Share by Type: 2024 VS 2031

Figure 4. CRO Features

Figure 5. CMC Features

Figure 6. CDMO Features

Figure 7. CMO Features

Figure 8. Global Small Molecule CXO Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Small Molecule CXO Market Share by Application: 2024 VS 2031

Figure 10. Pharmaceutical Case Studies

Figure 11. Biotechnology Case Studies

Figure 12. Small Molecule CXO Report Years Considered

Figure 13. Global Small Molecule CXO Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Small Molecule CXO Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Small Molecule CXO Market Share by Region: 2024 VS 2031

Figure 16. Global Small Molecule CXO Market Share by Players in 2024

Figure 17. Global Top Small Molecule CXO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule CXO as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Small Molecule CXO Revenue in 2024

Figure 19. North America Small Molecule CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Small Molecule CXO Market Share by Country (2020-2031)

Figure 21. United States Small Molecule CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Small Molecule CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Small Molecule CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Small Molecule CXO Market Share by Country (2020-2031)

Figure 25. Germany Small Molecule CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Small Molecule CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Small Molecule CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Small Molecule CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Small Molecule CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Small Molecule CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Small Molecule CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Small Molecule CXO Market Share by Region (2020-2031)

Figure 33. China Small Molecule CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Small Molecule CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Small Molecule CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Small Molecule CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Small Molecule CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Small Molecule CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Small Molecule CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Small Molecule CXO Market Share by Country (2020-2031)

Figure 41. Mexico Small Molecule CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Small Molecule CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Small Molecule CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Small Molecule CXO Market Share by Country (2020-2031)

Figure 45. Turkey Small Molecule CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Small Molecule CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Small Molecule CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. IQVIA Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 49. Labcorp Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 50. PPD Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 51. Wuxi Apptec Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 52. PharmaBlock Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 53. Asym Chemical Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 54. Jiuzhou Pharmaceutical Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 55. Pharmaron Beijing Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 56. Porton Pharma Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 57. ChemPartner Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 58. Tigermed Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 59. Shanghai Medicilon Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 60. VIVA Biotech Holdings Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 61. Chengdu Hitgen Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 62. Nanjing Genscript Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 63. ICON plc Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 64. PRA Health Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 65. Syneos Health Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 66. Lonza Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 67. Catalent Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 68. Thermo Fisher Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 69. DELPHARM Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 70. Aenova Group Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 71. Siegfried Holding AG Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 72. Recipharm AB Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 73. FAREVA SA Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 74. Almac Group Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 75. Cambrex Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 76. Charles River Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 77. CORDEN PHARMA Revenue Growth Rate in Small Molecule CXO Business (2020-2025)

Figure 78. Bottom-up and Top-down Approaches for This Report

Figure 79. Data Triangulation

Figure 80. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Small Molecule Drug Delivery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Small Molecule Injectable Market Research Report 2024

Innovative Small Molecule Targeted Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Commercialized Small Molecule for Therapy Market Research Report 2024

Global Prefilled Syringe Small Molecule Market Research Report 2025

5G C V2X Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Small Molecule Innovator CDMO Market Research Report 2025

Benzoquinone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chemical Supply Chain Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chemical IBC Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Small Molecule Nucleic Acid Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

High Precision OCXO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Low Power OCXO Market Research Report 2024

Small Molecule Protein Degradation Agent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

JLOX Molecular Sieve Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Small Molecule Targted Drug Market Insights Forecast to 2030

Programmable OCXO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

C V2X Chip Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Small Molecule API Development Service Market Research Report 2025

RELATED REPORTS

Global Geriatric Care Services Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-17Q6174

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Hospice Software Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8Z4276

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Geriatric Care Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8Q8325

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Allied Health Care Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29V19536

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions